proadifen has been researched along with Peptic Ulcer in 1 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
Peptic Ulcer: Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanayama, S | 1 |
1 other study available for proadifen and Peptic Ulcer
| Article | Year |
|---|---|
Metabolism of 6-chloro-5-cyclohexylindan-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent, in relation to ulcerogenic activity.
Topics: Animals; Anti-Inflammatory Agents; Bile; Carboxylic Acids; Cyclohexanes; Cytosol; Female; Glucuronat | 1974 |